PrEP

The intervention tested in the iPrEx trial is known as PrEP (pre-exposure prophylaxis), using a daily dose of the antiretroviral treatment drug TDF/FTC (brand name Truvada) to prevent HIV.

Mitchell Warren: No Turning Back: Pursuing the promise of HIV prevention Mitchell Warren 2010

We will also learn the results of a safety study looking at a strategy called PrEP in which researchers are investigating whether the use of antiretroviral drugs can help reduce the risk of HIV infection.

Mitchell Warren: Celebrating the Possible in the Fight against AIDS 2009

The idea of such "pre-exposure prophylaxis," known as PrEP, has gained traction in the past year, following results of other research showing a fall in infection rates among gay men taking AIDS drugs.

Yahoo! News: Business - Opinion 2011

Antiretroviral drugs that are taken orally before HIV exposure - an approach known as pre-exposure prophylaxis, or PrEP, which is also being tested in clinical trials - are likely to be equally effective against viruses transmitted through cells or bodily fluids because these drugs aim to stop transmission by stopping viral replication.

Scientific American 2010

These include trials of pre-exposure prophylaxis, or PrEP, which is evaluating the use of oral ARVs to reduce HIV risk in HIV negative people.

RedOrbit News - Technology 2010

Antiretroviral drugs that are taken orally before HIV exposure - an approach known as pre-exposure prophylaxis, or PrEP, which is also being tested in clinical trials - are likely to be equally effective against viruses transmitted through cells or bodily fluids because these drugs aim to stop transmission by stopping viral replication.

Scientific American 2010

Researchers from this group are also collaborating with public health researchers in testing hair to monitor pill-taking in clinical trials of single or dual antiretrovirals in high risk, HIV negative individuals to prevent infection with HIV (pre-exposure prophylaxis, known as PrEP, trials).

unknown title 2009

Researchers from this group are also collaborating with public health researchers in testing hair to monitor pill-taking in clinical trials of single or dual antiretrovirals in high risk, HIV negative individuals to prevent infection with HIV (pre-exposure prophylaxis, known as PrEP, trials).

PhysOrg.com - latest science and technology news stories 2009

We will also learn the results of a safety study looking at a strategy called PrEP in which researchers are investigating whether the use of antiretroviral drugs can help reduce the risk of HIV infection.

The Full Feed from HuffingtonPost.com Mitchell Warren 2009

Researchers from this group are also collaborating with public health researchers in testing hair to monitor pill-taking in clinical trials of single or dual antiretrovirals in high risk, HIV negative individuals to prevent infection with HIV (pre-exposure prophylaxis, known as PrEP, trials).

PhysOrg.com - latest science and technology news stories 2009